Regulations/Legal

Latest Issue of OR Manager
February 2025
Home Regulations/Legal

The Joint Commission: New Accelerate PI Dashboard Reports available

Editor's Note The Joint Commission on August 17 announced that refreshed Accelerate PI Dashboard Reports are now available for inpatient rehabilitation facilities (IRF), inpatient psychiatric facilities (IPF), and long-term acute care hospitals (LTCH) to provide data on a select subset of quality measures. The IPF reports contain data through the…

Read More

By: Judy Mathias
August 18, 2022
Share

President Biden signs healthcare bill into law

Editor's Note The Inflation Reduction Act (IRA) was signed into law by President Biden on Tuesday, August 16, at the White House, CBS News August 16 reports. This finalizes a signature piece of legislation aimed at lowering healthcare costs, fighting climate change, and raising taxes on corporations. The Senate passed…

Read More

By: Lauren McCaffrey
August 17, 2022
Share

CDC updates COVID-19 guidance

Editor's Note The Centers for Disease Control and Prevention (CDC) on August 11 updated its guidelines for COVID-19. The new recommendations focus on helping people better understand their risks, how to protect themselves and others, what actions to take if exposed, and what actions to take if they test positive…

Read More

By: Judy Mathias
August 15, 2022
Share

The Joint Commission to replace PNC Certification with ACPC program

Editor's Note The Joint Commission on August 10 announced that it will collaborate with the American College of Obstetricians and Gynecologists (ACOG) to offer Advanced Certification in Perinatal Care (ACPC) to accredited and nonaccredited hospitals and critical access hospitals with perinatal care programs, beginning January 1, 2023. The Joint Commission…

Read More

By: Judy Mathias
August 11, 2022
Share

Sponsored Message

Report: Many people with hepatitis C are not being treated

Editor's Note A new Centers for Disease Control and Prevention (CDC) Vital Signs report finds that a large number of people diagnosed with hepatitis C are not receiving treatment, Heathcare Purchasing News July 10 reports. Although hepatitis C is curable with oral medication, if left untreated, it can cause liver…

Read More

By: Lauren McCaffrey
August 11, 2022
Share

HHS releases tool to identify environmental hazards

Editor's Note On Wednesday August 10, the Department of Health and Human Services released the Environmental Justice Index (EJI), a tool used to identify health risks from pollution and other environmental hazards, the American Hospital Association July 10 reports. The EJI is the first national, geographic-driven tool utilized to measure…

Read More

By: Lauren McCaffrey
August 11, 2022
Share

Sponsored Message

Move to stretch monkeypox vaccine supply via smaller doses

Editor's Note On Tuesday, August 9, US officials announced they will modify dosing instructions for the Jynneos monkeypox vaccine to stretch the supply, US News & World Report July 10 reports. Currently, there are almost 9,500 known cases in the US, predominantly among gay and bisexual men. According to the…

Read More

By: Lauren McCaffrey
August 10, 2022
Share

FDA: Class I recall of Haimen Shengbang Viral Transport Media Containers

Editor's Note The Food and Drug Administration (FDA) on August 9 identified the recall by Haimen Shengbang Laboratory Equipment Co Ltd of its Viral Transport Media Containers as Class I, the most serious. The recall was initiated because the products were distributed in the US without authorization, clearance, or approval…

Read More

By: Judy Mathias
August 10, 2022
Share

Senate passes healthcare bill including drug price reforms

Editor's Note On Sunday, August 7, the Senate passed a spending bill allocating billions of dollars to climate reform and healthcare focused programs, including provisions that give “Medicare the power to negotiate drug prices for a small subset of drugs” and extend “enhanced Affordable Care Act subsidies” for 3 years,…

Read More

By: Tarsilla Moura
August 9, 2022
Share

FDA: Class I recall of North American Diagnostics’ COVID-19 test

Editor's Note The Food and Drug Administration (FDA) on August 1 identified the recall by North American Diagnostics of its Oral Rapid SARS-CoV-2 Rapid Antigen Test Kits as Class I, the most serious. These tests are being recalled because they were distributed in the US without authorization, clearance, or approval…

Read More

By: Judy Mathias
August 9, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat